A Medicare advisory panel has concluded that while ventricular assist devices can play a key role in managing end-stage heart failure, there are still considerable holes in the evidence base, particularly for patients who have less advanced disease.
CMS convened the Medicare Evidence Development and Coverage Advisory Committee at its Baltimore headquarters on Nov. 14 to gather independent...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?